# Pacylex Pharmaceuticals Inc. — Form D

Pacylex Pharmaceuticals Inc. of Calgary, A0, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-04. The offering totals $75K, of which $75K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-04-04
- Form: D
- Accession: 0001140361-24-017909
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $75K
- Amount sold: $75K
- Investors: 3
- Date of first sale: 2024-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509694

## Issuer

- Name: Pacylex Pharmaceuticals Inc.
- CIK: 0001866841
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 400 3rd Avenue SW, Calgary, A0, T2P 4H2
- Phone: 780-264-4295

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Luc G Berthiaume | Director | Calgary, A1 |
| Ajit G Gill | Director | Calgary, A0 |
| Mark Huson | Director | Calgary, A0 |
| Cindy Jacobs | Director | Calgary, A0 |
| John G Mackey | Director | Calgary, A0 |
| Nola G Masterson | Director | Calgary, A0 |
| Michael Weickert | Director | Calgary, A0 |
| Ryan G Heit | Executive Officer | Calgary, A0 |
| Michael Weickert | Executive Officer | Calgary, A0 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-06-14](https://search.stillhousedata.com/formd/0001567619-21-012046) | D | $7.2M | $7.2M |

## More

- [CIK 1866841 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1866841&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-24-017909.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.